Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
Article in Journal of Neuroinflammation (September 2023)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Journal of Neuroinflammation (September 2023)
Article in Pharmacoepidemiology and Drug Safety (August 2023)
Article in Multiple Sclerosis and Related Disorders (June 2023)